PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NHC vs. VRTX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Key characteristics


NHCVRTX
YTD Return43.77%20.43%
1Y Return84.98%29.31%
3Y Return (Ann)25.23%37.97%
5Y Return (Ann)12.60%19.10%
10Y Return (Ann)11.26%16.02%
Sharpe Ratio2.861.25
Sortino Ratio3.692.01
Omega Ratio1.481.26
Calmar Ratio5.762.61
Martin Ratio13.325.38
Ulcer Index6.47%5.78%
Daily Std Dev30.19%24.83%
Max Drawdown-94.71%-91.77%
Current Drawdown-4.28%-5.17%

Fundamentals


NHCVRTX
Market Cap$2.02B$126.19B
EPS$7.99-$1.91
PEG Ratio0.001.32
Total Revenue (TTM)$1.20B$10.61B
Gross Profit (TTM)$935.36M$9.14B
EBITDA (TTM)$137.08M-$147.50M

Correlation

-0.50.00.51.00.2

The correlation between NHC and VRTX is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

NHC vs. VRTX - Performance Comparison

In the year-to-date period, NHC achieves a 43.77% return, which is significantly higher than VRTX's 20.43% return. Over the past 10 years, NHC has underperformed VRTX with an annualized return of 11.26%, while VRTX has yielded a comparatively higher 16.02% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


0.00%10.00%20.00%30.00%40.00%JuneJulyAugustSeptemberOctoberNovember
34.92%
14.33%
NHC
VRTX

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NHC vs. VRTX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for National HealthCare Corporation (NHC) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


NHC
Sharpe ratio
The chart of Sharpe ratio for NHC, currently valued at 2.86, compared to the broader market-4.00-2.000.002.004.002.86
Sortino ratio
The chart of Sortino ratio for NHC, currently valued at 3.69, compared to the broader market-4.00-2.000.002.004.006.003.69
Omega ratio
The chart of Omega ratio for NHC, currently valued at 1.48, compared to the broader market0.501.001.502.001.48
Calmar ratio
The chart of Calmar ratio for NHC, currently valued at 5.76, compared to the broader market0.002.004.006.005.76
Martin ratio
The chart of Martin ratio for NHC, currently valued at 13.32, compared to the broader market0.0010.0020.0030.0013.32
VRTX
Sharpe ratio
The chart of Sharpe ratio for VRTX, currently valued at 1.25, compared to the broader market-4.00-2.000.002.004.001.25
Sortino ratio
The chart of Sortino ratio for VRTX, currently valued at 2.01, compared to the broader market-4.00-2.000.002.004.006.002.01
Omega ratio
The chart of Omega ratio for VRTX, currently valued at 1.26, compared to the broader market0.501.001.502.001.26
Calmar ratio
The chart of Calmar ratio for VRTX, currently valued at 2.61, compared to the broader market0.002.004.006.002.61
Martin ratio
The chart of Martin ratio for VRTX, currently valued at 5.38, compared to the broader market0.0010.0020.0030.005.38

NHC vs. VRTX - Sharpe Ratio Comparison

The current NHC Sharpe Ratio is 2.86, which is higher than the VRTX Sharpe Ratio of 1.25. The chart below compares the historical Sharpe Ratios of NHC and VRTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio1.002.003.004.005.00JuneJulyAugustSeptemberOctoberNovember
2.86
1.25
NHC
VRTX

Dividends

NHC vs. VRTX - Dividend Comparison

NHC's dividend yield for the trailing twelve months is around 1.84%, while VRTX has not paid dividends to shareholders.


TTM20232022202120202019201820172016201520142013
NHC
National HealthCare Corporation
1.84%2.53%3.80%3.11%3.13%2.38%2.52%3.10%2.31%3.14%2.13%2.34%
VRTX
Vertex Pharmaceuticals Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

NHC vs. VRTX - Drawdown Comparison

The maximum NHC drawdown since its inception was -94.71%, roughly equal to the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for NHC and VRTX. For additional features, visit the drawdowns tool.


-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-4.28%
-5.17%
NHC
VRTX

Volatility

NHC vs. VRTX - Volatility Comparison

National HealthCare Corporation (NHC) has a higher volatility of 12.11% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 9.28%. This indicates that NHC's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


4.00%6.00%8.00%10.00%12.00%JuneJulyAugustSeptemberOctoberNovember
12.11%
9.28%
NHC
VRTX

Financials

NHC vs. VRTX - Financials Comparison

This section allows you to compare key financial metrics between National HealthCare Corporation and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities



Values in USD except per share items